The biological characteristics of human third trimester amniotic fluid stem cells

Journal of International Medical Research

Volumn 37, Issue 1, 2009, Pages 105-112

  You, Q ^a   Tong, X ^a   Guan, Y ^a   Zhang, D ^a   Huang, M ^a   Zhang, Y ^b   Zheng, Jianhua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Red Cross Central Hospital   (China)

Author keywords

Amniotic fluid; Biological characteristics; Biological enginering; Human; Mesenchymal stem cells; Therapy; Third trimester

Indexed keywords

CYTOKINE; MEMBRANE ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMEDICAL ENGINEERING; BREECH PRESENTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THIRD TRIMESTER PREGNANCY; ADULT; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; CYTOLOGY; METABOLISM; PREGNANCY;

ADULT; AMNIOTIC FLUID; ANIMALS; BIOLOGY; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; OCTAMER TRANSCRIPTION FACTOR-3; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 64149096389     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700112     Document Type: Article

References (14)

1. Trounson A: A fluid means of stem cell generation. Nat Biotechnol 2007; 25: 62-63.
2. Siegel N, Rosner M, Hanneder M, et al: Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev 2007; 3: 256-264.
3. Zech NH, Shkumatov A, Koestenbauer S: The magic behind stem cells. J Assist Reprod Genet 2007; 24: 208-214.
4. Wu L, Chen W: Literature review on population and childbirth research in China in 2006. China Population Today 2008; 2: 14-21.
5. Pittenger MF, Mackay AM, Beek SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999; 294: 143-147.
6. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372-376.
7. Trosko JE: From adult stem cells to cancer stem cells: Oct-4 gene, cell-cell communication, and hormones during tumor promotion. Ann NY Acad Sci 2006; 1089: 36-58.
8. De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106.
9. Kim J, Lee Y, Kim H, et al: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75-90.
10. Ulloa-Montoya F, Verfaillie CM, Hu WS: Culture systems for pluripotent stem cells. J Biosci Bioeng 2005; 100: 12-27.
11. Fujikawa T, Oh SH, Pi L, et al: Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005; 166: 1781-1791.
12. Asano T, Sasaki K, Kitano Y, et al: In vivo tumor formation from primate embryonic stem cells. Methods Mol Biol 2006; 329: 459-467.
13. Thinyane K, Baier PC, Schindehütte J, et al: Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells. Brain Res 2005; 1045: 80-87.
14. Zhao Y, Wang H, Mazzone T: Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 2006; 312: 2454-2464.